TrialEBioMedicine2026

Partial restoration of counterregulatory circulating glucagon by dapagliflozin and low-dose glibenclamide in men with type 1 diabetes: in vitro studies and randomised clinical crossover trial.

Rui Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.